Position in DSGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,110,758
+$1,915,791 QoQ
Shares Held
353,197
+17.6% QoQ
Ownership
0.564%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 136 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. DSGN ranks #162 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in DSGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,110,758 | 353,197 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $3,194,967 | 300,279 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,688,043 | 286,572 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,232,861 | 296,529 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,221,682 | 362,518 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,442,298 | 373,653 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,394,729 | 388,125 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,811,843 | 336,774 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $1,130,104 | 337,345 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $1,439,852 | 357,284 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $988,254 | 372,927 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $762,890 | 323,259 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,045,849 | 324,738 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,591,179 | 275,768 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,863,872 | 279,130 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,743,380 | 283,695 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,612,308 | 258,022 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,408,198 | 211,034 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,539,240 | 212,015 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,804,401 | 122,832 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,695,630 | 135,527 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||